We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Could Biobanks Be the Currency for an Innovation Economy?

Article   Apr 13, 2021 | Erik Steinfelder and Olga Mikhaylova, Thermo Fisher Scientific

 
Could Biobanks Be the Currency for an Innovation Economy?
 
 
Advertisement
 

RELATED ARTICLES

LC-MS - What Is LC-MS, LC-MS Analysis and LC-MS/MS

Article

Coupling liquid chromatography (LC) with mass spectrometry (MS) has provided scientists with a powerful tool to meet stringent analytical demands and their versatility and efficiency means LC-MS instruments have become desirable in many laboratories. In this article, we consider how LC-MS works, what it tells us and highlight some of the technique's strengths and weaknesses.

READ MORE

Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents

Article

In this op-ed piece, Michael S. Kinch, director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis, explores the issue of eliminating patent protection for COVID-19 vaccines.

READ MORE

Toxicity Studies in Vaccine Clinical Development and Registration

Article

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. This article explores the full process.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE